ZIOPHARM Oncology competitorsClear all

ZIOPHARM Oncology's top competitors include Regenxbio, AveXis, Lexicon Pharmaceuticals and Syros Pharmaceuticals.
ZIOPHARM Oncology
ZIOPHARM Oncology
ZIOPHARM Oncology is an American biopharmaceutical company developing novel therapeutics for the treatment of cancer.
Regenxbio
Regenxbio
Regenxbio develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
AveXis
AveXis
AveXis is a biotech company developing innovative treatments for rare and life-threatening genetic diseases.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Syros Pharmaceuticals
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that is focused on treating diseases by mapping gene regulatory circuits.
Founding Date
Founding Date
2005
Founding Date
2009
Founding Date
2010
Founding Date
1995
Founding Date
2013
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Boston, US HQ
Locations
Rockville, US HQ
Locations
Bannockburn, US HQ
Locations
Spring, US HQ
Jersey, JE
Washington, US
Tucson, US
Tampa, US
Seattle, US
San Francisco, US
see more
Locations
Cambridge, US HQ
Employees
Employees
484% increase
Employees
19238% increase
Employees
N/A
Employees
20216% increase
Employees
7636% increase
Valuation ($)
Valuation ($)
682.1 m
Valuation ($)
1.8 b
Valuation ($)
N/A
Valuation ($)
588.7 m
Valuation ($)
256.7 m
Twitter followers
Twitter followers
N/A
Twitter followers
831
Twitter followers
1.4 k
Twitter followers
179
Twitter followers
974
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
25
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
22
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
1359421
Alexa Website Rank
771303
Alexa Website Rank
521139
Alexa Website Rank
708111
Alexa Website Rank
344248

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$218.5m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$63.2m (FY, 2018)
Revenue (est.)
$2.1m (FY, 2018)
Cost of goods
Cost of goods
N/A
Cost of goods
$9.6m (FY, 2018)
Cost of goods
N/A
Cost of goods
$2.5m (FY, 2018)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$208.9m (FY, 2018)
Gross profit
N/A
Gross profit
$60.7m (FY, 2018)
Gross profit
N/A
Net income
Net income
($53.1m) (FY, 2018)
Net income
$99.9m (FY, 2018)
Net income
($218.1m) (FY, 2017)
Net income
($120.5m) (FY, 2018)
Net income
($62.3m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 125.1m
Total funding raised
$ 118.9m
Total funding raised
$ 75m
Total funding raised
$ 244.7m
Total funding raised
$ 35m
For sources of this data, please see the company profile

View company profiles

Regenxbio
HQ
Rockville, US
Employees
192↑ 38% increase

Regenxbio develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.

View company
AveXis
HQ
Bannockburn, US

AveXis is a biotech company developing innovative treatments for rare and life-threatening genetic diseases.

View company
Lexicon Pharmaceuticals
HQ
Spring, US
Employees
202↑ 16% increase

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.

View company
Syros Pharmaceuticals
HQ
Cambridge, US
Employees
76↑ 36% increase

Syros Pharmaceuticals is a life sciences company that is focused on treating diseases by mapping gene regulatory circuits.

View company